Germany vs IDA blend: Antiretroviral therapy coverage
Germany
93.0%
in 2023
IDA blend
81.2%
in 2024
Germany rank
11th
IDA blend rank
13th
Antiretroviral therapy coverage over time
- Germany
- IDA blend
How they compare
Germany currently reports 93.0% against 81.2% in IDA blend, a difference of 11.8%.
That makes Germany's figure about 1.1 times IDA blend's.
Across all 14 years both countries report, Germany has been ahead every year.
Germany ranks 11th and IDA blend ranks 13th of 143 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.2% | 45.0% | 34.2% | Germany |
| 2020s | 92.0% | 73.7% | 18.3% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Germany or IDA blend?
- Germany, at 93.0% against 81.2% in IDA blend as of 2023.
- What is the difference in antiretroviral therapy coverage between Germany and IDA blend?
- 11.8%, with Germany ahead.
- How many years of comparable data are there for Germany and IDA blend?
- 14 years are reported by both, from 2010 to 2023.
- How do Germany and IDA blend rank globally for antiretroviral therapy coverage?
- Germany ranks 11th and IDA blend ranks 13th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.